EP2699261
Aðferð í meðferð við beinþynningu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
18.4.2012EP published:
11.7.2018EP application number:
12717002.5
EP translation filed:
27.9.2018Grant published:
15.11.2018EPO information:
European Patent Register
Max expiry date:
17.4.2032Expiry date:
17.4.2026Next due date:
30.4.2026
Title:
METHOD FOR TREATING OSTEOPOROSIS
Timeline
Today
18.4.2012EP application
11.7.2018EP Publication
27.9.2018Translation submitted
15.11.2018Registration published
17.4.2026Expires
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive, 91320-1799, Thousand Oaks, CA, US
Inventor
Name:
SAN MARTIN, JavierAddress:
Thousand Oaks, CA, US
Name:
WASSERMAN, ScottAddress:
Newbury Park, CA, US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201161477065 PDate:
19.4.2011Country:
US
Classification
Categories:
A61K 39/395
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 8.3.2019
Expires: 17.4.2020
Payer: Árnason Faktor
Number: 9
Paid: 10.3.2020
Expires: 17.4.2021
Payer: Árnason Faktor ehf.
Number: 10
Paid: 10.3.2021
Expires: 17.4.2022
Payer: Árnason Faktor ehf.
Number: 11
Paid: 10.3.2022
Expires: 17.4.2023
Payer: Árnason Faktor ehf.
Number: 12
Paid: 26.3.2023
Expires: 17.4.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 10.4.2024
Expires: 17.4.2025
Payer: Árnason Faktor ehf.
Number: 14
Paid: 8.4.2025
Expires: 17.4.2026
Payer: Árnason Faktor ehf.